NCT03805035View on ClinicalTrials.gov

Anti-histamines Promote Electroacupuncture Analgesia: Basic and Clinical Research

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 24, 2019

Primary Completion Date

June 27, 2019

Study Completion Date

June 30, 2019

Conditions
Pain
Interventions
DEVICE

electroacupuncture

Group 2 (n=10) EA at ST36 and GB34;intensity (2 mA), pulse width (1 ms), frequency (2 Hz)

DRUG

antihistamine(low dose) chlorpheniramine (Dexchlorpheniramine maleate)

Group 3 (n=10) EA at ST36 and GB34 plus chlorpheniramine (Dexchlorpheniramine maleate 2mg/tab, 1 tab);intensity (2 mA), pulse width (1 ms), frequency (2 Hz)

DRUG

antihistamine(high dose) chlorpheniramine (Dexchlorpheniramine maleate)

Group 4 (n=10) EA at ST36 and GB34 plus chlorpheniramine (Dexchlorpheniramine maleate2mg/tab, 2 tabs);intensity (2 mA), pulse width (1 ms), frequency (2 Hz)

DEVICE

acupuncture

Minimal needling at ST36 and GB34

Trial Locations (1)

404

China Medical University Hospital, Taichung

All Listed Sponsors
lead

China Medical University Hospital

OTHER

NCT03805035 - Anti-histamines Promote Electroacupuncture Analgesia: Basic and Clinical Research | Biotech Hunter | Biotech Hunter